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Abstract
In cluster randomised cross-over (CRXO) trials, clusters receive multiple treatments in a
randomised sequence over time. In such trials there is usually correlation between patients
in the same cluster. In addition, within a cluster, patients in the same period may be
more similar to each other than to patients in other periods. We demonstrate that it is
necessary to account for these correlations in the analysis to obtain correct Type I error
rates. We then use simulation to compare dierent methods of analysing a binary outcome
from a two-period CRXO design. Our simulations demonstrated that hierarchical models
without random eects for period-within-cluster, which do not account for any extra within-
period correlation, performed poorly with greatly inated Type I errors in many scenarios.
In scenarios where extra within-period correlation was present, a hierarchical model with
random eects for cluster and period-within-cluster only had correct Type I errors when
there were large numbers of clusters; with small numbers of clusters the error rate was
inated. We also found that generalised estimating equations did not give correct error rates
in any scenarios considered. An unweighted cluster-level summary regression performed best
overall, maintaining an error rate close to 5% for all scenarios, although it lost power when
extra within-period correlation was present, especially for small numbers of clusters. Results
from our simulation study show that it is important to model both levels of clustering in
CRXO trials, and that any extra within-period correlation should be accounted for.
1 Introduction
Cluster randomised trials are used in a number of situations including when an intervention
is aimed at the cluster level, when a parallel group trial would be unfeasible, or for logistical
reasons. However, cluster randomisation can lead to a substantial reduction in power compared
to an individually randomised trial. Power in a cluster randomised trial can be increased by
adding more clusters, or by recruiting more people from each cluster. However, there is a limit
on the amount of power that can be gained using the latter approach [1], and the ability to
increase the number of clusters in a trial may be limited by nancial or logistical constraints.
An alternative method that may increase the power of a cluster randomised trial is to add a
cross-over element [2, 3]. Cluster randomised cross-over (CRXO) trials use a design in which
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clusters receive multiple treatments in a random order. For example, in a CRXO trial with two
treatments and two periods, clusters would be randomly assigned to receive either treatment A
followed by treatment B, or B and then A. Including a cross-over element in a trial with cluster
randomisation allows each cluster to act as its own control, which may reduce the number of
clusters or patients needed to achieve the desired power [2, 3]. The CRXO design may also help
to counteract imbalances in baseline patient characteristics that can occur in cluster randomised
trials with a small number of clusters [3].
Despite the potential advantages of a CRXO study design, the cross-over element leads to
a more complicated data structure, which in turn leads to a more complex analysis. If the
analysis is not handled appropriately it could lead to incorrect or misleading results. However,
a systematic review of CRXO trials [4, 5] deemed that only 10% (14/139) of analyses used
potentially appropriate methods that accounted for both the cluster and cross-over components
of the design. To date, much of the research regarding methods of analysis for CRXO trials
has focused on continuous outcomes [6] or case studies of individual CRXO trials [7]. Forbes
et al. [8] have considered the analysis of a binary outcome from a CRXO trial, but with an
emphasis on cluster-level summary methods, in which cluster-level summaries are modelled
instead of individual-level data. They also performed a limited assessment of individual-level
models using generalised estimating equations (GEEs) with an identity link. It is currently
unclear which individual-level methods of analysis are most appropriate for binary outcomes
from CRXO trials, and in particular whether hierarchical models might be a useful approach.
In this paper we use simulation to compare methods of estimating a treatment eect for a
binary outcome. We consider both models that estimate a treatment odds ratio (OR), including
hierarchical models and GEEs, and also cluster-level summary methods of analysis that estimate
the treatment eect as a dierence in proportions. Our simulation study incorporates a wide
range of scenarios and uses a standard statistical software package, Stata 13 [9], to implement
the methods. We only consider a CRXO design with two time periods with a dierent set of
patients in each period.
We start by outlining the structure of the data that are obtained from such a trial design in
Section 2. In Sections 3 and 4 we outline the methods of analysis examined, and describe the
structure of our simulation study. In Sections 5-7 we present results from our simulation study.
We discuss the application of the CRXO design to a particular trial, TRIGGER2, in Section 8.
Discussions and conclusions are given in Sections 9 and 10.
2 The structure of CRXO data
In cluster randomised trials outcomes from individuals in the same cluster are frequently more
similar to each other than they are to outcomes from individuals in dierent clusters. This
correlation between outcomes in the same cluster, called the intra-cluster correlation coecient
(ICC), violates the usual assumption that all patients are independent, and therefore requires
that the clustering be taken into account in the analysis [1, 10{12].
CRXO trials have a more complicated structure. In addition to outcomes being correlated
within clusters, there may be clustering within the same cluster-period (any given period within
a single cluster): within each cluster, outcomes in one period may be more similar to each other
than they are to outcomes in another period. Equivalently, there are two potential sources of
variation | between clusters, and between periods within a cluster. For example, this may
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occur in a trial where the members of clinical sta dier between periods. Dierent teams
of clinical sta may have diering approaches to concomitant care that may in turn produce
diering health outcomes of their patients. Two ICCs are therefore required to describe the
data. In this paper we use one ICC to represent the correlation between two outcomes in the
same cluster-period, and one ICC to represent the extra correlation between two outcomes in
the same cluster-period compared with outcomes in dierent periods.
In Figure 1 we show two dierent ways of modelling how the mean outcome changes in
each cluster and period for a simple CRXO trial with three clusters and two periods. The
mean outcome could be the proportion of successful events, or the odds of a successful event,
in the case of a binary outcome. Here, we use hierarchical models to model the log odds of a
successful event. These models are discussed further in Section 3.1. We consider these models
in the absence of a treatment eect for clarity. The rst model, shown in panel A, assumes the
mean outcome varies across clusters, and across time periods; however, the variation over time
is assumed to be the same for all clusters:
logit(PrfYijk = 1jcig) = + j + ci ; (1)
where Yijk is the outcome for person k in period j of cluster i, Yijk = 1 is considered to be a
\successful" event,  is an intercept, ci is a cluster eect that could be modelled either as a
xed or a random eect,  is a xed period eect and j is an indicator variable that is 1 for
the second period and 0 for the rst. This model assumes that all observations in a cluster are
equally correlated regardless of whether they belong to the same period, once the xed eect
of period has been taken into account.
The second model (panel B) assumes that the mean outcome varies across clusters and over
time, and that the variation across time periods is dierent for each cluster:
logit(PrfYijk = 1jci; pijg) = + j + ci + pij ; (2)
where pij is a normally distributed random eect for cluster-period (i.e. a random eect for
cluster-by-period interaction) with mean 0 and variance component 2p. This model assumes
that all observations within a cluster are correlated, and that within a cluster two observations
in the same period are more correlated than two observations from dierent periods.
2.1 Impact of ignoring extra correlation within cluster-periods
The model in Panel A of Figure 1 is sometimes used to analyse CRXO trials [5]. These models
assume that outcomes from all patients within a cluster are equally correlated, regardless of
which period they are in. If this assumption is incorrect, and patient outcomes in the same
period are more similar to each other than to outcomes in other periods, then cluster-period
will be a source of non-ignorable clustering, a concept that is discussed in Ref. [13]. Briey,
a source of clustering is non-ignorable if both the outcomes and treatment assignments within
the cluster are correlated. Treatment assignments within a cluster-period are correlated, as all
patients in the cluster-period receive the same treatment; hence the correlation is equal to one.
Outcomes within a cluster-period will also be correlated if patients are more similar to other
patients in the same cluster-period than to patients in other periods within the cluster.
When clustering is non-ignorable it must be included in the trial analysis to obtain correct
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Figure 1: A sketch to illustrate how mean outcomes might be modelled in a CRXO trial. Each
line represents a cluster, and each dot a cluster-period. Panel A shows a model where the mean
outcome varies between the three clusters and by period, but the period eect is assumed to be
the same for all clusters. Panel B allows the outcomes to change dierently over time depending
on the cluster.
Type I error rates. For CRXO trials, ignoring extra cluster-period correlation in the analysis
may lead to inated Type I error rates, increasing the chance of a false-positive result. Therefore,
if there is extra correlation within cluster-period, the model in Panel A will give incorrect and
potentially misleading results. Hence, a model such as that in Panel B should be used instead.
2.2 CRXO trials and intra-cluster correlation coecients
As discussed in Section 2, in a CRXO trial there are two possible types of correlation | within a
cluster, and additional correlation within a cluster-period | and two ICCs are therefore required
to describe the data. We denote the rst as c [6], the correlation between two outcomes in the
same cluster-period, and dene it on the logistic scale (see e.g. Refs. [14, 15] for a discussion of
ICC denitions for binary outcomes on the logistic scale) as:
c =
2c + 
2
p
2c + 
2
p + 
2=3
; (3)
where 2c is the variance between the cluster means, 
2
p is the variance between the cluster-period
means conditional on the cluster mean, and  is the mathematical constant. This ICC is based
on an underlying linear model for a latent continuous outcome [16]. The 2=3 term represents
the residual variance of a standard logistic model. The continuous outcome is then dichotomised
to produce a binary outcome following a logistic model. c represents the correlation between
two outcomes in the same cluster-period on the original continuous (logistic) scale.
We denote our second ICC p and dene it as:
p =
2p
2c + 
2
p + 
2=3
: (4)
It represents the additional correlation between two outcomes in the same cluster-period com-
pared with two outcomes from dierent periods in the same cluster:
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p = Corr(Y

ijk; Y

ijk0)  Corr(Y ijk; Y ij0k0) ; (5)
where:
Corr(Y ijk; Y

ijk0) =
2c + 
2
p
2c + 
2
p + 
2=3
= c ; (6)
is the correlation between two latent continuous outcomes Y ijk, Y

ijk0 from cluster i, period j
and subjects k and k0, and:
Corr(Y ijk; Y

ij0k0) =
2c
2c + 
2
p + 
2=3
=  ; (7)
is the correlation between two outcomes in cluster i but dierent periods j and j0.
3 Methods of analysis
In this section we start by outlining a number of methods of analysis which we then evaluate
in Sections 5-7 via a simulation study. We use the subscript i = 1; : : : ; C to denote cluster,
where C is the total number of clusters, j = 1; 2 to denote period, and k = 1; : : : ; nij to denote
individual, with nij individuals in cluster i during period j. The number of events in each
cluster-period will be denoted Yij =
Pnij
k=1 Yijk, where Yijk is the binary outcome for person k
in period j and cluster i.
3.1 Individual-level methods
Hierarchical models
Hierarchical models can be used to describe data with a multi-level structure [16]. Variables
that describe the structure of the data, such as cluster, can be included either as xed eects,
each with their own regression coecient, or as random eects, which follow a distribution.
Hierarchical models allow complex correlation structures to be modelled in a way that utilises
the power available from individual-level data. They are also easily extended to account for
baseline covariates. [16]
In this study we consider four dierent hierarchical models. The rst model has xed eects
for cluster:
logit(PrfYijk = 1g) = + ij + j + i ; (8)
where  is an overall mean,  is the treatment eect, ij and j are indicator variables for
treatment and period respectively,  is a xed period eect, and i are xed eects for cluster.
Note that clusters can be modelled as xed eects for a CRXO trial because each cluster receives
both the intervention and control, and such models utilise within-cluster information alone to
estimate treatment eects. We refer to this model as \Fixed" as it has xed eects for cluster.
The second model has a random eect for cluster rather than xed eects:
logit(PrfYijk = 1jcig) = + ij + j + ci ; (9)
where ci is a normally distributed random eect with mean zero and variance 
2
c . We refer to
this model as \Random" as it uses random eects for the clusters.
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These two models allow the mean outcome to change going from period 1 to period 2, but
all clusters change by the same amount, as in panel A of Figure 1. As discussed in Section 2.1,
if there is extra correlation within cluster-period then these models will be mis-specied and
may give incorrect and misleading results.
We also consider two further models. The rst has xed eects for cluster and a random
eect for cluster-period:
logit(PrfYijk = 1jpijg) = + ij + j + i + pij ; (10)
where pij is a normally distributed random eect with variance 
2
p, and other terms are dened
as above. We refer to this model as \Fixed-random".
Lastly we consider a model with random eects for both cluster and for period within cluster,
which we refer to as \Random-random":
logit(PrfYijk = 1jci; pijg) = + ij + j + ci + pij ; (11)
The variance components 2c and 
2
p from this model are used in the ICC denitions given in
Section 2.2.
The Fixed-random and Random-random models allow the variation seen in panel B of
Figure 1, where mean outcome in each cluster can change over time in a dierent way.
Generalised estimating equations
An alternative to likelihood based methods such as hierarchical models is to use generalised
estimating equations (GEEs) [16{18]. In GEEs marginal probabilities are modelled and the
resulting odds ratios (ORs) are population averaged [17, 18]. Unlike the ORs from the Random-
random hierarchical model that compares the odds of outcome from two people chosen at
random within the same cluster-period, population averaged ORs compare the odds of outcome
of two people picked at random from the entire study population regardless of which cluster or
cluster-period they belong to. Cluster and cluster-period are averaged over, and hence GEEs
model marginal probabilities rather than probabilities that are conditional on cluster-period.
The two types of OR are often very similar in practice, but they estimate two dierent population
parameters. The extent to which the two ORs dier will depend on the size of the variance
components in the Random-random hierarchical model [1].
In GEEs clustering is not accounted for by adding terms to the model, but the correlations
are modelled explicitly in a working correlation matrix [16]. Standard errors (SEs) can be calcu-
lated using a robust sandwich estimator which can account for mis-specication of the working
correlation matrix, although this relies on a sucient number of clusters being available [16, 17].
The basic marginal model we consider for the GEEs is:
logit(PrfYijk = 1g) = + ij + j ; (12)
where PrfYijk = 1g is now a marginal probability and  is a population averaged treatment
eect.
This basic marginal model can be used in conjunction with dierent working correlation
matrices, both with and without a robust sandwich estimator. To our knowledge, it is not
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currently possible to specify a working correlation matrix that captures two dierent correlations
for cluster and cluster-period in the Stata command xtgee [19], and manual coding of such
a working correlation matrix and its inverse in the GEE algorithm would be required. We
therefore chose to look at working correlation matrices that model the higher level of clustering
(an exchangeable correlation matrix that captures a constant correlation within clusters but
ignores any clustering at the cluster-period level) and that model the lower level of clustering
(an \exchangeable in cluster-period" matrix that captures correlation within cluster-period but
ignores additional correlation within clusters). The exchangeable correlation matrix assumes
that there is a common correlation  between all observations in a cluster, regardless of which
period the observation belongs to, corresponding to 2p = 0 in the Random-random hierarchical
model. The \exchangeable in cluster-period" correlation matrix assumes that observations
within the same period are exchangeable with a common correlation , but observations from
dierent periods in the same cluster are uncorrelated. This is equivalent to the assumption
that the variance 2c is zero and that there is only correlation between outcomes in the same
cluster-period, as would be the case in a parallel group cluster randomised trial. This working
correlation assumes c = p, or  = 0, and therefore does not exploit the correlation between
individuals in dierent cluster-periods that allows the cross-over element to improve eciency
over a cluster randomised design. We also consider an independent working correlation matrix.
Estimates of the SE from all GEEs were considered both with and without the use of a
robust sandwich estimator.
3.2 Linear regressions on summary measures
Cluster-level methods can be used to model summary statistics for each cluster-period. The
main advantages of cluster-level methods are their robustness and ease of implementation, while
a potential disadvantage is that they do not make full use of the data which may lead to a loss
in power [10].
We can t a linear regression to model the proportion of events in each cluster-period. Since
we are analysing cluster-period summaries we no longer need to account for correlations within
cluster-period, but we do still need to account for cluster eects. Dening Pij = Yij=nij as the
proportion of events in period j of cluster i, we can t the following linear regression model
with xed cluster eects:
Pij = + ;Lij + j + i + ij ; (13)
where  is an overall mean, ;L is the treatment eect and ij is an indicator variable for
treatment of interest,  is a xed period eect and j is an indicator variable for period, i
are xed cluster eects, and ij is a normally distributed residual error term with mean zero
and variance 2e . We add an L subscript to ;L to highlight that the treatment eect given
by this model is measured on the linear scale, i.e. it corresponds to a dierence in proportions
rather than an OR as in the individual-level models. Note that using xed eects and random
eects for cluster in this model will give identical results [20]. This model is equivalent to the
cluster-level method used by Turner et al. [6].
An unweighted linear regression assumes that all data points have the same error variance.
It is also possible to use weights in conjunction with this regression model, which may help to
increase eciency if this assumption does not hold. We therefore chose to look at the following
three weightings in our simulation study, in addition to the unweighted regression. The rst
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weights by size of cluster, with the weight for cluster i set proportional to [6, 8]:
1
ni1
+
1
ni2
 1
; (14)
where ni1 and ni2 are the number of patients in cluster i in the rst and second periods re-
spectively. This weighting assumes that c =  or equivalently that p = 0 (there is no extra
cluster-period correlation), and that the variances for the two treatments are equal and the
same for all clusters.
The second set of weights are based on the inverse of the variance of Pi2   Pi1 and are
a combination of cluster-period size and estimated ICC. The weights for each cluster are set
proportional to [6, 8]: 
1 + (ni1   1)^c
ni1
+
1 + (ni2   1)^c
ni2
  2^
 1
; (15)
where ^c is a sample estimate of c and ^ is a sample estimate of the correlation between two
outcomes in dierent periods in the same cluster (and is equal to the dierence between c and
p | see Section 2.2). These weights relax the assumption that c = , although still assume
that the variances are the same for both treatments. For a full derivation and description of
assumptions for these weights see Ref. [8].
The third set of weights uses the inverse of the binomial variance for each cluster-period:
pij(1  pij)
nij
 1
: (16)
A zero-cell correction, a technique used in meta-analysis [21] in which 0.5 is added to each pij
and 1  pij for any pij equal to zero or one, was used to avoid undened weights.
In addition to these three methods of weighting, we also considered a variety of other weight-
ings which gave results that were very similar to the size and ICC weights specied above |
see Sections 1 and 6 of the online appendix for more details.
Some of these weights require estimates of the ICCs on the linear scale. For c we use an
ANOVA estimator that is dened in references such as [10, 15, 22, 23]. For the correlation  we
use the pairwise estimator that is given in Donner et al. in [23]. Both of these denitions are
given in Section 2 of the online appendix.
4 Simulation study: data generation
In our simulation study we started by conducting two small initial simulation studies to identify
which methods of analysis appeared to perform well (Section 5). This was followed by a full
factorial simulation study on the subset of methods that performed well in the initial simulation
study (Sections 6 and 7). In this section we describe the data generation process used in our
simulation study. The parameters used in our simulations are outlined in Sections 5-7.
We generated data sets using Equation (11). Simulations were carried out in Stata 13 [9].
Data sets were generated such that the number of subjects varied across clusters and cluster-
periods. The number of patients in each cluster-period was generated in the following way:
 Let m represent the average number of patients per cluster-period across the study. A
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value of m was chosen for each scenario (see Section 6 for further details).
 A value for the average size of each cluster in the study was sampled from a negative
binomial distribution with mean m and standard deviation (SD) 0:65  m. A value
of 0.65 was chosen as this is the coecient of variation found in general practice list
size by Eldridge, Ashby and Kerry [24] (see Section 4 of the online appendix for further
discussion). Any zeros were redrawn. This gives a number mi for each cluster, with all
mi greater than zero, representing the average size of a particular cluster.
 For each cluster, we selected the number of individuals in each cluster-period by sampling
from a normal distribution with mean mi and SD 0:65=100mi. A coecient of variation
of 0:65=100 was chosen to ensure a smaller variation in size between periods than variation
across clusters. Numbers less than or equal to zero were redrawn.
For each scenario we compared the dierent methods of analysis in terms of the mean
estimated treatment eect, bias in the estimated SEs, failure rates, power, and Type I error
rate across 5000 simulated data sets. This number of replications gives a Monte Carlo error of
0.3% when estimating the Type I error rate, assuming a true rate of 5% [25]. Methods were
classed as failing to run when applied to a specic simulated data set if they did not produce
parameter and standard error estimates, for example if the model did not converge.
Bias in the estimated SEs was calculated as the ratio of the model based SE to the empirical
SE; empirical SEs were calculated as the SD of the individual treatment eects, and model
based SEs were calculated as the square root of the mean of the treatment estimate variances.
All summary measures were calculated only for scenarios where the analysis method did not
fail to run (e.g. due to non-convergence).
5 Initial simulation study
We started by conducting two small simulation studies to rule out any methods of analysis that
did not perform well across any scenarios. The rst set of simulations varied the number of
clusters while keeping other parameters xed; the second set of simulations varied the size of p
while keeping other parameters xed. For each set of simulations, we set the treatment eect to
zero to evaluate the Type I error rate. We used an event rate of 15% in the control arm during
the rst period, which corresponds to  = log

0:15
1 0:15

=  1:735 in Equation (11), with a xed
period eect OR of 0.85 ( = log(0:85) =  0:163 in Equation (11)), and a c of 0.062.
For the scenarios looking at increasing the number of clusters we used a p of 0.023, which
corresponds to variance components of (2c = 0:137, 
2
p = 0:081). The following values were
used for the number and size of clusters:
 6 clusters, with an average of 200 patients per cluster-period,
 12 clusters, with an average of 60 patients per cluster-period,
 20 clusters, with an average of 34 patients per cluster-period,
 30 clusters, with an average of 22 patients per cluster-period,
 50 clusters, with an average of 14 patients per cluster-period,
 80 clusters, with an average of 8 patients per cluster-period.
The average numbers of patients per cluster-period were found by simulation as those required to
give 80% power using an unweighted cluster-summary level regression for (c = 0:062; p = 0).
Note that, since p = 0 for this ICC combination, c = , i.e. the correlation between two
observations in a cluster is the same regardless of period.
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For the scenarios increasing p we used 6 or 30 clusters, with their respective average sizes of
200 and 22 patients per cluster-period. A c of 0.062 was used, as before, and p was allowed to
take the following values: 0.001, 0.005, 0.01 and 0.05. These ICCs correspond to the following
variance component combinations: (2c = 0:214, 
2
p = 0:003), (0.200, 0.017), (0.182, 0.035) and
(0.042, 0.176).
A discussion of our reasons for particular parameter choices is given in Section 4 of the
online appendix.
In these initial simulations we looked at the methods outlined in Section 3; consisting of an
unweighted linear regression on the cluster-level summaries plus six dierent types of weighting,
four hierarchical models and GEEs implemented in three dierent ways, each with and with-
out robust SEs. Wald test statistics for all hierarchical models and GEEs were based on the
normal distribution. Test statistics for the cluster-level summary regressions were based on a
t-distribution with C   2 degrees of freedom. In the online appendix we also include results
using a t-distribution with C   2 degrees of freedom for the hierarchical models and GEEs, to
enable direct comparison with the results from the cluster-level summary regressions.
5.1 Results of initial simulations and discussion
The eect of increasing number of clusters on Type I error is displayed in Figure 2. The eect
of increasing p on Type I error is shown in Figure 3. We also looked at some weightings and
GEEs that are not presented in the gures but that displayed very similar behaviours to other
models. The full results for all methods can be found in the online appendix in Tables 1-7.
The Fixed-random hierarchical model in Equation (10) that uses xed eects for cluster and
a random eect for cluster-period was found to have a very high failure rate, for as few as 12
clusters (see Table 1 of the online appendix). We therefore chose not to include this method in
any further scenarios. All GEEs displayed in the gures use robust SEs.
None of the methods showed any bias in the treatment eect estimates. However, we found
that many of the methods have Type I errors considerably above 5%. The hierarchical models
had Type I errors that were inated to over 10% for scenarios with only a few clusters and a non-
zero p. This was also the case for most of the GEEs, while the GEE using an exchangeable in
cluster-period correlation matrix had Type I errors that were generally too conservative, falling
to below 4% in several of the scenarios. This is because this working correlation matrix does
not exploit the correlation between individuals in dierent cluster-periods.
The unweighted linear regression gave a Type I error rate of between 4.2 and 5.0% across
all scenarios considered in this initial study. We therefore chose to study this model further in
our factorial simulation study. The linear regression that is weighted by size has inated Type I
errors (above 5.6%) for all numbers of clusters when p is 0.023. For 6 clusters the Type I error
is inated for p values of 0.005 and above. However, we decided to look further at this method
across a wider range of scenarios since it is a commonly used weighting scheme in parallel group
cluster randomised trials.
The ICC weighted regression suers from a relatively high failure rate (up to 4% | see
Table 6 of the online appendix) in some scenarios, in addition to having a slightly inated Type
I error. Note that if the ICCs estimated from the data gave negative weights to some clusters,
which led to those clusters being excluded from the analysis, we classed these data sets as failing
to run. We therefore did not take this method forward. The binomial variance weighting gave
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Figure 2: Type I errors across dierent numbers of clusters: the top left panel shows the linear
regression methods, the top right panel shows the hierarchical models and the bottom left panel
shows the GEEs. Random-random is a hierarchical model with random eects for cluster and
cluster-period. Random and Fixed have random and xed eects for cluster respectively. GEEs
are labelled by their working correlation matrix, and all use robust SEs. Simulation parameters
are set to an event rate of 15%, no treatment eect, xed period eect OR of 0.85, c = 0:062
and p = 0:023. For clarity, Type I errors of greater than 10% have been plotted together and
labelled individually.
appropriate Type I errors in the initial simulation study that increased number of clusters, but
gave an inated Type I error for larger values of p in the second initial simulation study. We
therefore did not take this method forward.
Importantly, the Random hierarchical model, which has random eects for cluster but ig-
nores any extra correlation within cluster-periods, did not perform well in these initial scenarios.
It has an inated Type I error when (c = 0:062; p = 0:023) even for 80 clusters, where the
Type I error is 6.4%. Although the Type I error is close to the nominal value of 5% for smaller
p values (up to p = 0:005) when there are 30 clusters, the false positive rate is too high for all
values of p considered when there are only 6 clusters. Aside from a small number of scenarios
(30 clusters, p  0:005), the false positive rate for this method is inated, in the worst cases
to over 40% (6 clusters, p = 0:05). The results for this method, and for the Fixed model, were
so poor that they were not carried forward to the full factorial simulation.
Although the Random-random hierarchical model does have inated error rates for small
numbers of clusters there is a suggestion that this behaviour improves for larger numbers of
clusters | the Type I error rate is only 5.4% for 80 clusters. Although for six clusters the Type
I error is 5.7% even for a very small p of 0.001, when the number of clusters is increased to
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Figure 3: Type I errors across dierent values of p: the top panel shows the linear regression
methods, the middle panel shows the hierarchical models and the bottom panel shows the
GEEs. The left hand column is for 6 clusters, and the right is for 30 clusters. Other simulation
parameters are set to an event rate of 15%, no treatment eect, xed period eect OR of 0.85,
and c = 0:062.
30 the Type I error is close to nominal until p is raised to above 0.01. The Random-random
model also performs consistently better than any of the other hierarchical models. We therefore
decided to take forward this model to the factorial simulation study.
6 Factorial simulation study
As described in Section 5.1, we took forward three methods to a fully factorial simulation study:
an unweighted linear regression, a linear regression weighted by size and the Random-random
hierarchical model. We have provided the Stata [9] code for these methods in Section 3 of the
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online appendix.
The simulation parameters we varied in this study were:
 Event rate in the control arm during the rst period: 15% or 45% ( = log

0:15
1 0:15

=
 1:735 or  = log

0:45
1 0:45

=  0:201 in Equation (11)).
 Treatment eect: no treatment eect or a non-zero treatment eect (OR 0.5 for an event
rate of 15%, corresponding to a decrease to an event rate of around 8%,  = log(0:5) =
 0:693 in Equation (11); OR 0.75 for an event rate of 45%, corresponding to an event
rate on treatment of 38%,  = log(0:75) =  0:288).
 Number of clusters: 6 or 30.
 ICC combinations: (c = 0:023, p = 0), (0.062, 0), (0.023, 0.01) and (0.062, 0.023), with
values quoted on the logistic (underlying latent continuous variable) scale | see Section
4 of the online appendix for a discussion of these choices. These combinations correspond
to variance components of (2c = 0:077, 
2
p = 0), (0.217, 0), (0.044, 0.034) and (0.137,
0.081), where 2c and 
2
p are dened in Equation (11). Note that scenarios with p = 0
will correspond to the variation seen in Panel A of Figure 1. When p is non-zero the
variation will be as in Panel B.
 Power/number of patients per cluster-period: for each scenario, we chose the average
number of patients per cluster-period, m, such that an unweighted linear regression model
gave the desired power (based on a t-distribution with C   2 degrees of freedom) using
values for c and p of 0.062 and 0 respectively. This was done by using simulation. The
event rate was set as for the particular scenario. We used numbers of patients that were
needed to give either 80% or 90% power. This corresponds to 200 (80% power) and 330
(90% power) for 6 clusters and 15% event rate, 22 (80% power) and 31 (90% power) for
30 clusters and 15% event rate. For 45% event rate, averages of 400 and 600 patients per
cluster-period were used for 6 clusters, and 55 and 75 for 30 clusters.
In addition a xed period eect was generated in each data set (OR 0.85 for an event rate of
15%, corresponding to a decrease of around 2% in event rate to about 13% in the second period,
 = log(0:85) =  0:163 in Equation (11); OR 0.92 for an event rate of 45%, corresponding to
the same absolute decrease of around 2%,  = log(0:92) =  0:083).
6.1 Results
In this Section we present the results of our factorial simulation study. Full tabulated results
can be found in the Section 6 of the online appendix.
6.1.1 Scenarios with an event rate of 15%
Figure 4 shows how the Type I error varies across the ICC combinations for the three methods
for 6 clusters (left-hand column), and an event rate of 15%. For 6 clusters with an average
of 200 patients per cluster-period (top left panel), the Type I error for the unweighted linear
regression is consistently below 5% for all ICC combinations (range: 4.2 to 4.4%). However,
the power drops from around 80% to below 60% for a p of 0.023, as can be seen in the top left
panel of Figure 5.
For scenarios with zero p the size-weighted regression has Type I errors close to or below
5% and gives better power than the unweighted linear regression. This is as expected since the
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variance in these scenarios depends on cluster size only and not p. However, when there is
a non-zero p the Type I error for this method rises to 5.7% for 6 clusters and 200 patients.
This behaviour is also observed for the Random-random hierarchical model, with the Type I
error rising to over 10% for non-zero p combinations. The power for this model is the highest,
but for scenarios with non-zero p this is not a valid comparison given the greatly inated false
positive rates.
We used a normal distribution to calculate p-values for the Random-random model. Using
a t-distribution with C   2 degrees of freedom can help to reduce inated Type I errors, but
when the Type I error is already close to nominal the use of the t-distribution produces overly
conservative results (see tables in the online appendix). For example, for 6 clusters, an average
of 200 patients per cluster-period, 15% event rate, and (c = 0:062, p = 0:023), use of the t-
distribution gives a Type I error rate of 5.6% compared with 16.0% using a normal distribution.
However for the same number of clusters and patients but with (c = 0:023, p = 0) the Type
I error rate is 0.4% using a t-distribution, compared with 4.2% for a normal distribution. In
addition, use of the t-distribution is not always sucient to reduce the Type I error to the
nominal rate. For example, for 6 clusters, 330 patients per cluster-period, 15% event rate, and
(c = 0:062, p = 0:023), use of the t-distribution gives a Type I error rate of 7.1% which is still
slightly inated. It may therefore be benecial to use a more sophisticated degree-of-freedom
correction, such as the Kenward-Roger method [26, 27]. However, more advanced degree-of-
freedom corrections are not always routinely available in standard statistical software packages,
and further research would be needed to assess any benets of using such a correction.
Increasing the average number of patients per cluster-period to 330, shown in the bottom
left panel of Figures 4 and 5, results in a similar pattern of Type I errors and power for the
three models.
For 30 clusters, shown in the right-hand column of Figure 4, the unweighted linear regression
again gives appropriate Type I errors across all ICC combinations. The decrease in power for
the non-zero p combinations is much less for 30 clusters, as seen in the right hand column of
Figure 5. Both the size-weighted regression and the hierarchical model display inated Type I
errors for some of the scenarios with larger ICCs, particularly when p is non-zero, although to
a lesser extent than with 6 clusters. They again both provide more power than the unweighted
regression, but sometimes at the cost of an inated Type I error rate.
6.1.2 Scenarios with an event rate of 45%
Results for an event rate of 45% were qualitatively similar to those for an event rate of 15%,
and can be found in Section 5 of the online appendix. Unlike the scenarios with a 15% event
rate, the failure rate of the Random-random hierarchical model was found to be high for some
parameter values. For an event rate of 15% the failure rate was found to be lower than 0.5% in
all scenarios. For an event rate of 45% and 30 clusters the failure rate was similarly low, but
for only 6 clusters it varied between 1% and 9.3%, with the highest failure rates in scenarios
with large numbers of patients per period per cluster and high ICCs.
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Figure 4: Type I errors across dierent ICC combinations: combination one is (c=0.023, p=0),
combination two is (0.062, 0), combination three is (0.023, 0.01) and combination four is (0.062,
0.023). Graphs are labelled by number of clusters and average number of patients per cluster-
period. Other simulation parameters are set to an event rate of 15%, no treatment eect, and
a xed period eect OR of 0.85.
7 Further exploration of the Random-random hierarchical model
Given the poor performance of the Random-random hierarchical model for certain ICC values
and numbers of clusters, we explored this model further over a wider range of simulation param-
eters. We ran further simulations using just the Random-random model as an analysis method
for the following parameters:
 Event rate: 15 %.
 Treatment eect: no treatment eect or a treatment OR of 0.5.
 Numbers of clusters: 6, 12, 20, 30, 50, 80 and 100.
 ICC combinations: (c = 0:023, p = 0), (0.062, 0), (0.023, 0.01) and (0.062, 0.023).
 Power: numbers of patients to give 80% power for an ICC combination (0.062, 0). This
corresponds to 200 patients per cluster-period for 6 clusters, 60 for 12 clusters, 34 for 20
clusters, 22 for 30 clusters, 14 for 50 clusters, 8 for 80 clusters and 6 for 100 clusters.
A xed period OR of 0.85 was used.
7.1 Results
Figure 6 shows how the Type I error and power vary across the ICC combinations and numbers
of clusters for the Random-random model. Full tabulated results can be found in Section 6 of
the online appendix.
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Figure 5: Power across dierent ICC combinations. Simulation parameters and ICC combina-
tions are as in Figure 4 except that the treatment OR is 0.5.
For ICC combinations 1 and 2, i.e. those with p = 0, the Type I error remains close to
nominal levels for all numbers of clusters studied. For non-zero p, the Type I error grows as
the number of clusters is decreased. At least 50 clusters are needed for (c = 0:023; p = 0:01)
to get a Type I error close to 5%, and this rises to at least 80 clusters for the largest ICC
combination of (c = 0:062; p = 0:023).
The right hand panel of Figure 6 shows that the power remains high for all scenarios con-
sidered, although this comparison is not truly valid because of the elevated Type I error rates
for scenarios with high ICCs and small numbers of clusters.
These results show that if there is extra correlation within a cluster-period, it is necessary
to have a large number of clusters for the Random-random model to give Type I errors close to
5%.
8 Application to TRIGGER2
We now demonstrate how the results from the simulation study can be applied to inform the
design and analysis of a CRXO trial. TRIGGER1 [28{30] was a parallel group, cluster ran-
domised feasibility trial which compared two dierent haemoglobin thresholds for red blood cell
transfusions for patients with acute upper gastrointestinal bleeding. One of the primary aims
of TRIGGER1 was to inform the design and feasibility of a phase 3 trial, TRIGGER2.
TRIGGER1 took place in 6 UK hospitals, each of which recruited for a xed period of 6
months. It is anticipated that TRIGGER2 will take place in between 20 and 40 hospitals, and
that the primary outcome will be all-cause mortality. Due to the limited number of clusters
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Figure 6: Type I errors (left hand panel) and power (right hand panel) for the Random-
random hierarchical model, increasing the numbers of clusters across dierent ICC combinations:
combination one is (c=0.023, p=0), combination two is (0.062, 0), combination three is (0.023,
0.01) and combination four is (0.062, 0.023). The average number of patients per cluster-period
is 200 for 6 clusters, 60 for 12 clusters, 34 for 20 clusters, 22 for 30 clusters, 14 for 50 clusters,
8 for 80 clusters and 6 for 100 clusters. Other simulation parameters are set to an event rate
of 15%, a xed period eect OR of 0.85, and either no treatment eect (left hand panel) or a
treatment OR of 0.5 (right hand panel).
available, as well as the likelihood that the intervention would result in a relatively small (though
still clinically important) treatment dierence, TRIGGER2 may be designed as a CRXO trial
to increase power and reduce the number of patients required in each cluster.
Our simulation study has demonstrated that it is important to consider not only c but also
p when calculating the sample size or choosing the analysis method for a CRXO trial. Because
TRIGGER1 was a parallel group cluster randomised trial, estimating p is dicult. However,
a crude estimate can be obtained by splitting the follow-up period into two halves; 0-3 months,
and 4-6 months. From this, we estimated p as 0.012.
This ICC estimate is large enough that it should be accounted for in both the sample size
estimate and the analysis. The sample size could be calculated using an analytical formula that
allows for between cluster-period variation [8, 31] or by using simulation [32]. The simulation
package created by Reich et al. [32] assumes that p is zero and would therefore not be suitable
for use in situations where it is suspected to be non-zero. Because of the relatively small number
of clusters, an individual-level analysis based on a hierarchical model is not likely to perform
well. Therefore, an unweighted cluster-level summary analysis may be preferred.
It should be noted that our estimate of p from TRIGGER1 may not be a reliable estimate.
We have assumed that each period lasts for three months, but the p estimate may not be
appropriate for dierent period lengths. Additionally, this estimate is based on only 6 clusters
and will therefore have a large error associated with it.
This demonstrates the challenges in trying to estimate p to help inform the design and anal-
ysis of CRXO trials. Estimates are unlikely to be routinely available from previously reported
CRXO trials, and estimates from existing datasets may face similar issues as TRIGGER1.
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9 Discussion
Cluster randomised cross-over trials may be useful in settings where recruiting larger numbers
of clusters is not possible and carry-over of an intervention will not be a problem. The potential
for carry-over should be carefully considered before using a cross-over design since any residual
eects of treatment that are present in later periods will bias estimates of treatment eect [20].
If there is no carry-over, using a cross-over element in the design may increase the power and
help counteract imbalance between the arms if there are only a small number of clusters [3].
However, it adds another level of clustering, periods within clusters, which may complicate the
sample size calculation and analysis.
We have demonstrated that it is necessary to model p in the analysis, and results from
our simulation study indicate that Type I errors can be substantially inated (to over 20% in
some cases) if this is not done appropriately. Although it may be tempting to model only the
highest level of clustering for simplicity, our results show that this leads to inated Type I errors.
Using a hierarchical model without a random eect for cluster-period results in higher Type I
errors than a model which does include such a term. In addition using the Random-random
model when p is zero does not result in inappropriate Type I errors. It is therefore important
to model all levels of clustering, not just the highest. At present, this does not seem to be
generally acknowledged when analysing CRXO trials. The systematic review conducted by
Arnup et al. [4, 5] deemed that out of 127 analyses performed at the individual-level, only four
used potentially appropriate methods that account for both levels of clustering of the CRXO
design. Fifty-four of the individual-level analyses did not account for either the clustering or
cross-over, and no analyses used a random eect for cluster-period.
If p is zero then the unweighted and size-weighted cluster-level summary methods and the
Random-random hierarchical model all appear to perform well. When p is non-zero, our results
demonstrate that the number of clusters in a CRXO trial is very important in dierentiating
between methods. Choosing an appropriate analysis for a small number of clusters becomes
very dicult. This is especially concerning given that not being able to recruit a large number
of clusters may be a common reason for conducting a CRXO trial. Arnup et al.'s review of 91
CRXO trials found the median number of clusters to be 9 (IQR 4-21) [5].
We found that an unweighted cluster-level regression method is robust across all scenarios
considered, but that this method can lose power when p is non-zero, especially for small
numbers of clusters. These results agree with those in Forbes et al. [8], who found that cluster
methods generally work well. Given this loss of power, it might be tempting to use a size-
weighted linear regression. However, we found that this method did not work well in a wide
variety of dierent scenarios.
Despite our results showing the robustness of an unweighted cluster-level regression method,
the review by Arnup et al. [5] found that only 9% (12/139) of analyses were performed at the
cluster-level. We have demonstrated that care needs to be taken as to whether it is appropriate
to use an individual-level method of analysis such as the Random-random hierarchical model
with random eects for cluster and cluster-period. For small numbers of clusters, as may be the
case in many CRXO trials in practice, the Type I error is inated for this model. Adopting a
degree-of-freedom correction such as the Kenward-Roger method may reduce the Type I error
rate in these scenarios, although further study is required to verify this. For such study, we note
that implementation of Kenward-Roger degrees of freedom in generalised linear mixed models
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is available in the SAS software, but we are not aware currently of its implementation in Stata
or R outside of linear mixed models.
As discussed in Section 8, it can be dicult to nd a reliable estimate for p for use in a
sample size calculation or when deciding on a method of analysis. In the absence of a good
estimate for the ICC, we recommend assuming a non-zero eect and accounting for it in the
analysis. This will help to ensure correct condence intervals and p-values, and avoid inating
the Type I error rate. For example, Gireaudeau et al. recommend in some circumstances
using p set to half the size of c [31]. A strategy such as this is preferable to alternatives
such as assuming that p is 0 and ignoring it in the analysis (which could lead to substantially
increased Type I error rates), or using data from the trial to estimate the ICC and choosing
whether to account for clustering by period in the analysis based on this estimate (as this type
of preliminary testing strategy has been shown to perform poorly in many situations [33{35]).
Given the particular issues of loss of power and small numbers of clusters that have been
highlighted by our simulation study, it would also be important to consider these issues at the
stage of planning the sample size to be used for a CRXO trial. Giraudeau et al. [31] and Forbes
et al. [8] have both published some work on sample size calculations for CRXO trials. It may
also be worth calculating sample size by simulation, in order to consider the eect of likely
values of p and numbers of clusters, extending the work of Reich et al. [32] to the case of
non-zero p. The risk of using too few clusters has also been discussed in Ref. [36].
Our study contained some limitations. For the hierarchical models, we considered only a
logit link as to our knowledge it is not possible to specify other link functions with a Random-
random model for a binary outcome in Stata. However, the Random-random model with other
link functions, such as log or identity, could be easily specied in other software packages such
as SAS; although further research is required to ensure these models perform adequately.
In our simulation study, we only considered CRXO trials with two time periods and dierent
individuals in each period. The Arnup systematic review [4, 5] of 91 CRXO trials found that
58 trials (69% of those with number of periods available) had two periods only, and that only
27 trials (30%) included the same individuals in all periods, suggesting that our results will be
relevant to many CRXO trials that have been conducted. The methods of analysis considered in
this paper could be extended to account for more periods. The methods could also be extended
to other trial designs with multiple periods and clustering, such as stepped wedge trials. Such
trials may have non-zero p and, given our results, it would be important to account for this in
the analysis. However, more research would be needed to evaluate how the methods perform in
those scenarios. For example, autocorrelation may become an important factor with increasing
numbers of periods.
We simulated data sets with unequal numbers of patients per cluster-period. Our results may
not be generalisable to situations with dierent distributions of patients across cluster-periods,
since loss of power for unequal cluster sizes versus equal cluster sizes depends on the cluster
size distribution [37]. However, allowing cluster sizes to vary is more realistic than assuming
equal cluster sizes and is likely to reect what will happen in a CRXO trial in practice, so our
results oer a pragmatic comparison of methods and show what happens to the power under
one possible data generation method.
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10 Conclusions
Ignoring p in a CRXO trial can lead to inated Type I errors if p is non-zero. Given that it
will be very dicult to completely rule out the existence of a non-zero p, an analysis method
that accounts for this should generally be chosen.
However, accounting for p is dicult. A hierarchical model with random eects for cluster
and cluster-period requires a very large number of clusters if there is additional correlation
within a cluster-period. For values of the extra correlation considered in this study, at least 50-
80 clusters were required for nominal Type I error rates, with more clusters required for larger
dierences in correlation. An unweighted cluster-level summary method can be used with a
smaller number of clusters but may lose power. If using this method we therefore recommend
that the sample size used is large enough to account for this potential loss of power. Sample
size simulations which account for both levels of clustering may be of use to establish how large
a trial is needed.
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